New hope pill tested for Tough-to-Treat lung cancer
Disease control
Recruiting now
This early-stage study is testing a new oral medication called HJ-004-02 for people with advanced non-small cell lung cancer that has a specific genetic change (EGFR mutation) and has stopped responding to standard treatments. The main goals are to find a safe dose, see how the b…
Phase: PHASE1 • Sponsor: Tongji University • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC